ARCHIVES

ESAs Increase Risk of Death by 11 Percent, Blood Clots by 59 Percent, Meta-Analysis Finds; Study To Be Updated At ASCO.

This article is from The Cancer Letter archive.

Vol. 33 No. 21 | June 1, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Friedman Named FDA Deputy Commissioner; Parkinson To Lead CTEP; Walsh Resigns

September 22, 1995

FDA Opponents Claim Abuses; Agency Doesn’t Attend Hearing

July 28, 1995

Argentine Human Rights Violations Continue, But Some Improvement Seen

October 20, 1978

In Brief: New Mount Sinai Cancer Center Gets $7 Million; Jules Harris Named Rush Cancer Center Director

July 25, 1986

Zometa Can Reduce Risk Of Skeletal-Related Events

August 26, 2011

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

March 12, 1976